Zhenqi Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Zhenqi Zhou has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Alexander R. Strumwasser
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
6 shared publicationsLinsey Stiles
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
5 shared publications- Timothy M. Moore
Division of Cardiology, Department of Medicine, University of California, Los Angeles, USA
5 shared publications - Andrea L. Hevener
Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 90095, USA
4 shared publications Aidan Yackly
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles, Los Angeles, CA, USA
3 shared publicationsAmanda J. Lin
Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, David Geffen School of Medicine University of California, Los Angeles, Los Angeles, CA, USA; Department of Chemical and Systems Biology, Stanford School of Medicine, Stanford, CA, USA
3 shared publications
Latest Publications
- 1 December 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (6) , C1718-1733
Beyond mitochondrial fission: emerging roles of Drp1 in skeletal muscle physiology and disease
Dynamin-related protein 1 (Drp1) is best recognized as the primary regulator of mitochondrial fission. However, emerging evidence indicates that Drp1 is a multifaceted regulator of skeletal muscle physiology whose functions extend well beyond its canonical role in mitochondrial fission. Recent studies have identified novel roles of Drp1 in regulating substrate utilization, calcium homeostasis, reactive oxygen species signaling, respiratory complex assembly, and mitochondrial-to-nuclear signaling, including mechanisms independent of its canonical fission activity. Importantly, Drp1 regulation in skeletal muscle is highly context-dependent, as both excessive and insufficient Drp1 activity can disrupt skeletal muscle homeostasis. For example, excessive Drp1 activation and mitochondrial fragmentation are associated with insulin resistance, type 2 diabetes, and neuromuscular diseases, whereas severe or prolonged Drp1 deficiency impairs mitochondrial quality control, bioenergetics, induces muscle atrophy, and compromises the exercise training adaptations. Therefore, the biological consequences of Drp1 modulation are highly context-dependent and influenced by the metabolic and physiological state of skeletal muscle. In this review, we summarize the molecular regulation and emerging functions of Drp1 in skeletal muscle, with particular emphasis on fission-independent mechanisms and Drp1 dysregulation in metabolic and neuromuscular diseases. We further discuss pharmacological and nonpharmacological strategies for modulating Drp1 signaling and highlight emerging approaches for skeletal muscle-specific targeting. Collectively, current evidence supports a paradigm in which skeletal muscle Drp1 functions as a multifaceted regulator of mitochondrial and skeletal muscle homeostasis, highlighting the therapeutic potential of modulating Drp1 activity to optimize mitochondrial and muscle health across different physiological and pathological contexts.
- 1 December 2026
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 331 (6) , C1718-1733
Beyond mitochondrial fission: emerging roles of Drp1 in skeletal muscle physiology and disease
Dynamin-related protein 1 (Drp1) is best recognized as the primary regulator of mitochondrial fission. However, emerging evidence indicates that Drp1 is a multifaceted regulator of skeletal muscle physiology whose functions extend well beyond its canonical role in mitochondrial fission. Recent studies have identified novel roles of Drp1 in regulating substrate utilization, calcium homeostasis, reactive oxygen species signaling, respiratory complex assembly, and mitochondrial-to-nuclear signaling, including mechanisms independent of its canonical fission activity. Importantly, Drp1 regulation in skeletal muscle is highly context-dependent, as both excessive and insufficient Drp1 activity can disrupt skeletal muscle homeostasis. For example, excessive Drp1 activation and mitochondrial fragmentation are associated with insulin resistance, type 2 diabetes, and neuromuscular diseases, whereas severe or prolonged Drp1 deficiency impairs mitochondrial quality control, bioenergetics, induces muscle atrophy, and compromises the exercise training adaptations. Therefore, the biological consequences of Drp1 modulation are highly context-dependent and influenced by the metabolic and physiological state of skeletal muscle. In this review, we summarize the molecular regulation and emerging functions of Drp1 in skeletal muscle, with particular emphasis on fission-independent mechanisms and Drp1 dysregulation in metabolic and neuromuscular diseases. We further discuss pharmacological and nonpharmacological strategies for modulating Drp1 signaling and highlight emerging approaches for skeletal muscle-specific targeting. Collectively, current evidence supports a paradigm in which skeletal muscle Drp1 functions as a multifaceted regulator of mitochondrial and skeletal muscle homeostasis, highlighting the therapeutic potential of modulating Drp1 activity to optimize mitochondrial and muscle health across different physiological and pathological contexts.
- Open Access
- 8 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (19) , eaec0795
Drp1 regulates mitochondrial health and controls skeletal muscle mass through the Erk1/2-Nur77 pathway
The maintenance of skeletal muscle mass relies on mitochondrial quality control, including balanced dynamics and mitophagy. Dynamin-related protein 1 (Drp1), a central mediator of mitochondrial fission, is essential for these processes, yet its role in muscle mass regulation remains incompletely defined. Here, we show that acute Drp1 deletion in the skeletal muscle increases Parkin-mediated mitochondrial degradation, reduces mitochondrial DNA (mtDNA) content, and leads to severe muscle atrophy. Although dual deletion of Drp1 and Parkin restores mtDNA content, muscle loss persists. Mechanistically, Drp1 loss impairs mitochondrial respiratory chain activity, suppressing extracellular signal–regulated kinase 1/2 (Erk1/2) signaling and down-regulating the nuclear receptor subfamily 4 group A member 1 (Nur77). Pharmacologic β2-adrenergic receptor activation with clenbuterol reactivated Erk1/2, restored Nur77 expression, and rescued muscle atrophy. These findings define a Drp1-Erk1/2-Nur77 signaling axis linking mitochondrial integrity to skeletal muscle mass and identify a potential therapeutic target for muscle degeneration in mitochondrial and metabolic diseases.
- 8 May 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (19) , eaec0795
Open AccessDrp1 regulates mitochondrial health and controls skeletal muscle mass through the Erk1/2-Nur77 pathway
The maintenance of skeletal muscle mass relies on mitochondrial quality control, including balanced dynamics and mitophagy. Dynamin-related protein 1 (Drp1), a central mediator of mitochondrial fission, is essential for these processes, yet its role in muscle mass regulation remains incompletely defined. Here, we show that acute Drp1 deletion in the skeletal muscle increases Parkin-mediated mitochondrial degradation, reduces mitochondrial DNA (mtDNA) content, and leads to severe muscle atrophy. Although dual deletion of Drp1 and Parkin restores mtDNA content, muscle loss persists. Mechanistically, Drp1 loss impairs mitochondrial respiratory chain activity, suppressing extracellular signal–regulated kinase 1/2 (Erk1/2) signaling and down-regulating the nuclear receptor subfamily 4 group A member 1 (Nur77). Pharmacologic β2-adrenergic receptor activation with clenbuterol reactivated Erk1/2, restored Nur77 expression, and rescued muscle atrophy. These findings define a Drp1-Erk1/2-Nur77 signaling axis linking mitochondrial integrity to skeletal muscle mass and identify a potential therapeutic target for muscle degeneration in mitochondrial and metabolic diseases.
- Open Access
- 9 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (2) , eadz1385
ERα activates NAMPT/IL-33 signaling to enhance beige thermogenesis and metabolic fitness
Beige adipocytes are inducible thermogenic fat cells that emerge within white adipose tissue (WAT) in response to thermogenic stimuli and confer metabolic benefits. However, obesity impairs the generation of beige adipocytes, and the underlying mechanisms remain poorly understood. Here, we show that obesity leads to a loss of adipose progenitor cells (APCs) in WAT, accompanied by reduced estrogen (E2) levels and nicotinamide phosphoribosyltransferase (NAMPT) expression. Supplementation with E2 or nicotinamide mononucleotide (NMN), an NAMPT-derived nicotinamide adenine dinucleotide (NAD + ) precursor, restores beige adipogenesis in diet-induced obese mice. Mechanistically, estrogen receptor α (ERα) in APCs is required for beige fat formation by promoting Nampt transcription. We further demonstrate that NAMPT is both necessary and sufficient to drive APC proliferation and differentiation, with interleukin-33 (IL-33) acting downstream to mediate these effects. These findings uncover a critical ERα/NAMPT/IL-33 axis that preserves progenitor function and thermogenic capacity, offering a potential therapeutic strategy to combat obesity-induced beige fat failure and associated metabolic dysfunction.
- 9 January 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (2) , eadz1385
Open AccessERα activates NAMPT/IL-33 signaling to enhance beige thermogenesis and metabolic fitness
Beige adipocytes are inducible thermogenic fat cells that emerge within white adipose tissue (WAT) in response to thermogenic stimuli and confer metabolic benefits. However, obesity impairs the generation of beige adipocytes, and the underlying mechanisms remain poorly understood. Here, we show that obesity leads to a loss of adipose progenitor cells (APCs) in WAT, accompanied by reduced estrogen (E2) levels and nicotinamide phosphoribosyltransferase (NAMPT) expression. Supplementation with E2 or nicotinamide mononucleotide (NMN), an NAMPT-derived nicotinamide adenine dinucleotide (NAD + ) precursor, restores beige adipogenesis in diet-induced obese mice. Mechanistically, estrogen receptor α (ERα) in APCs is required for beige fat formation by promoting Nampt transcription. We further demonstrate that NAMPT is both necessary and sufficient to drive APC proliferation and differentiation, with interleukin-33 (IL-33) acting downstream to mediate these effects. These findings uncover a critical ERα/NAMPT/IL-33 axis that preserves progenitor function and thermogenic capacity, offering a potential therapeutic strategy to combat obesity-induced beige fat failure and associated metabolic dysfunction.
- Open Access
- 5 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (14) , eadl0389
Drp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
The dynamin-related guanosine triphosphatase, Drp1 (encoded by Dnm1l ), plays a central role in mitochondrial fission and is requisite for numerous cellular processes; however, its role in muscle metabolism remains unclear. Here, we show that, among human tissues, the highest number of gene correlations with DNM1L is in skeletal muscle. Knockdown of Drp1 (Drp1-KD) promoted mitochondrial hyperfusion in the muscle of male mice. Reduced fatty acid oxidation and impaired insulin action along with increased muscle succinate was observed in Drp1-KD muscle. Muscle Drp1-KD reduced complex II assembly and activity as a consequence of diminished mitochondrial translocation of succinate dehydrogenase assembly factor 2 (Sdhaf2). Restoration of Sdhaf2 normalized complex II activity, lipid oxidation, and insulin action in Drp1-KD myocytes. Drp1 is critical in maintaining mitochondrial complex II assembly, lipid oxidation, and insulin sensitivity, suggesting a mechanistic link between mitochondrial morphology and skeletal muscle metabolism, which is clinically relevant in combatting metabolic-related diseases.
- 5 April 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 10 (14) , eadl0389
Open AccessDrp1 controls complex II assembly and skeletal muscle metabolism by Sdhaf2 action on mitochondria
The dynamin-related guanosine triphosphatase, Drp1 (encoded by Dnm1l ), plays a central role in mitochondrial fission and is requisite for numerous cellular processes; however, its role in muscle metabolism remains unclear. Here, we show that, among human tissues, the highest number of gene correlations with DNM1L is in skeletal muscle. Knockdown of Drp1 (Drp1-KD) promoted mitochondrial hyperfusion in the muscle of male mice. Reduced fatty acid oxidation and impaired insulin action along with increased muscle succinate was observed in Drp1-KD muscle. Muscle Drp1-KD reduced complex II assembly and activity as a consequence of diminished mitochondrial translocation of succinate dehydrogenase assembly factor 2 (Sdhaf2). Restoration of Sdhaf2 normalized complex II activity, lipid oxidation, and insulin action in Drp1-KD myocytes. Drp1 is critical in maintaining mitochondrial complex II assembly, lipid oxidation, and insulin sensitivity, suggesting a mechanistic link between mitochondrial morphology and skeletal muscle metabolism, which is clinically relevant in combatting metabolic-related diseases.
- Open Access
- 12 May 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (5) , 112499
Conserved multi-tissue transcriptomic adaptations to exercise training in humans and mice
- 12 May 2023
- Published by Elsevier in Cell Reports
- Vol. 42 (5) , 112499
Open AccessConserved multi-tissue transcriptomic adaptations to exercise training in humans and mice
- Open Access
- 4 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Parkin regulates adiposity by coordinating mitophagy with mitochondrial biogenesis in white adipocytes
Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control. However, the mechanisms by which Parkin connects mitochondrial homeostasis with cellular metabolism in adipose tissue remain unclear. Here, we demonstrate that Park2 gene (encodes Parkin) deletion specifically from adipose tissue protects mice against high-fat diet and aging-induced obesity. Despite a mild reduction in mitophagy, mitochondrial DNA content and mitochondrial function are increased in Park2 deficient white adipocytes. Moreover, Park2 gene deletion elevates mitochondrial biogenesis by increasing Pgc1α protein stability through mitochondrial superoxide-activated NAD(P)H quinone dehydrogenase 1 (Nqo1). Both in vitro and in vivo studies show that Nqo1 overexpression elevates Pgc1α protein level and mitochondrial DNA content and enhances mitochondrial activity in mouse and human adipocytes. Taken together, our findings indicate that Parkin regulates mitochondrial homeostasis by balancing mitophagy and Pgc1α-mediated mitochondrial biogenesis in white adipocytes, suggesting a potential therapeutic target in adipocytes to combat obesity and obesity-associated disorders.
- 4 November 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-14
Open AccessParkin regulates adiposity by coordinating mitophagy with mitochondrial biogenesis in white adipocytes
Parkin, an E3 ubiquitin ligase, plays an essential role in mitochondrial quality control. However, the mechanisms by which Parkin connects mitochondrial homeostasis with cellular metabolism in adipose tissue remain unclear. Here, we demonstrate that Park2 gene (encodes Parkin) deletion specifically from adipose tissue protects mice against high-fat diet and aging-induced obesity. Despite a mild reduction in mitophagy, mitochondrial DNA content and mitochondrial function are increased in Park2 deficient white adipocytes. Moreover, Park2 gene deletion elevates mitochondrial biogenesis by increasing Pgc1α protein stability through mitochondrial superoxide-activated NAD(P)H quinone dehydrogenase 1 (Nqo1). Both in vitro and in vivo studies show that Nqo1 overexpression elevates Pgc1α protein level and mitochondrial DNA content and enhances mitochondrial activity in mouse and human adipocytes. Taken together, our findings indicate that Parkin regulates mitochondrial homeostasis by balancing mitophagy and Pgc1α-mediated mitochondrial biogenesis in white adipocytes, suggesting a potential therapeutic target in adipocytes to combat obesity and obesity-associated disorders.
- Top Cited Papers
- 22 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6613) , 1399-1406
Liver-heart cross-talk mediated by coagulation factor XI protects against heart failure
Tissue-tissue communication by endocrine factors is a vital mechanism for physiologic homeostasis. A systems genetics analysis of transcriptomic and functional data from a cohort of diverse, inbred strains of mice predicted that coagulation factor XI (FXI), a liver-derived protein, protects against diastolic dysfunction, a key trait of heart failure with preserved ejection fraction. This was confirmed using gain- and loss-of-function studies, and FXI was found to activate the bone morphogenetic protein (BMP)–SMAD1/5 pathway in the heart. The proteolytic activity of FXI is required for the cleavage and activation of extracellular matrix–associated BMP7 in the heart, thus inhibiting genes involved in inflammation and fibrosis. Our results reveal a protective role of FXI in heart injury that is distinct from its role in coagulation.
- 22 September 2022
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 377 (6613) , 1399-1406
Top Cited PapersLiver-heart cross-talk mediated by coagulation factor XI protects against heart failure
Tissue-tissue communication by endocrine factors is a vital mechanism for physiologic homeostasis. A systems genetics analysis of transcriptomic and functional data from a cohort of diverse, inbred strains of mice predicted that coagulation factor XI (FXI), a liver-derived protein, protects against diastolic dysfunction, a key trait of heart failure with preserved ejection fraction. This was confirmed using gain- and loss-of-function studies, and FXI was found to activate the bone morphogenetic protein (BMP)–SMAD1/5 pathway in the heart. The proteolytic activity of FXI is required for the cleavage and activation of extracellular matrix–associated BMP7 in the heart, thus inhibiting genes involved in inflammation and fibrosis. Our results reveal a protective role of FXI in heart injury that is distinct from its role in coagulation.
- Open Access
- 9 November 2021
- Published by Wiley in Physiological Reports
- Vol. 9 (21) , e15068
Effect of voluntary exercise upon the metabolic syndrome and gut microbiome composition in mice
In this study, we sought to determine if endurance exercise is sufficient to prevent or ameliorate the development of metabolic syndrome and its associated diseases and the impact of physical activit...
- 9 November 2021
- Published by Wiley in Physiological Reports
- Vol. 9 (21) , e15068
Open AccessEffect of voluntary exercise upon the metabolic syndrome and gut microbiome composition in mice
In this study, we sought to determine if endurance exercise is sufficient to prevent or ameliorate the development of metabolic syndrome and its associated diseases and the impact of physical activit...
- 5 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (555)
Estrogen receptor α controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling
ERα gene expression is heritable in humans and prevents obesity in mice by improving mitochondrial function via adipocyte Polg1 expression.
- 5 August 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 12 (555)
Estrogen receptor α controls metabolism in white and brown adipocytes by regulating Polg1 and mitochondrial remodeling
ERα gene expression is heritable in humans and prevents obesity in mice by improving mitochondrial function via adipocyte Polg1 expression.
- Open Access
- 19 June 2020
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11, 690
Mitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice
Duchenne muscular dystrophy (DMD) is characterized by rapid wasting of skeletal muscle. Mitochondrial dysfunction is a well-known pathological feature of DMD. However, whether mitochondrial dysfunction occurs before muscle fiber damage in DMD pathology is not well known. Furthermore, the impact upon heterozygous female mdx carriers (mdx/+), who display dystrophin mosaicism, has received little attention. We hypothesized that dystrophin deletion leads to mitochondrial dysfunction, and that this may occur before myofiber necrosis. As a secondary complication to mitochondrial dysfunction, we also hypothesized metabolic abnormalities prior to the onset of muscle damage. In this study, we detected aberrant mitochondrial morphology, reduced cristae number, and large mitochondrial vacuoles from both male and female mdx mice prior to the onset of muscle damage. Furthermore, we systematically characterized mitochondria during disease progression starting before the onset of muscle damage, noting additional changes in mitochondrial DNA copy number and regulators of mitochondrial size. We further detected mild metabolic and mitochondrial impairments in female mdx carrier mice that were exacerbated with high-fat diet feeding. Lastly, inhibition of the strong autophagic program observed in adolescent mdx male mice via administration of the autophagy inhibitor leupeptin did not improve skeletal muscle pathology. These results are in line with previous data and suggest that before the onset of myofiber necrosis, mitochondrial and metabolic abnormalities are present within the mdx mouse.
- 19 June 2020
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 11, 690
Open AccessMitochondrial Dysfunction Is an Early Consequence of Partial or Complete Dystrophin Loss in mdx Mice
Duchenne muscular dystrophy (DMD) is characterized by rapid wasting of skeletal muscle. Mitochondrial dysfunction is a well-known pathological feature of DMD. However, whether mitochondrial dysfunction occurs before muscle fiber damage in DMD pathology is not well known. Furthermore, the impact upon heterozygous female mdx carriers (mdx/+), who display dystrophin mosaicism, has received little attention. We hypothesized that dystrophin deletion leads to mitochondrial dysfunction, and that this may occur before myofiber necrosis. As a secondary complication to mitochondrial dysfunction, we also hypothesized metabolic abnormalities prior to the onset of muscle damage. In this study, we detected aberrant mitochondrial morphology, reduced cristae number, and large mitochondrial vacuoles from both male and female mdx mice prior to the onset of muscle damage. Furthermore, we systematically characterized mitochondria during disease progression starting before the onset of muscle damage, noting additional changes in mitochondrial DNA copy number and regulators of mitochondrial size. We further detected mild metabolic and mitochondrial impairments in female mdx carrier mice that were exacerbated with high-fat diet feeding. Lastly, inhibition of the strong autophagic program observed in adolescent mdx male mice via administration of the autophagy inhibitor leupeptin did not improve skeletal muscle pathology. These results are in line with previous data and suggest that before the onset of myofiber necrosis, mitochondrial and metabolic abnormalities are present within the mdx mouse.